Modulation of paraoxonase (PON1) activity LG Costa, A Vitalone, TB Cole, CE Furlong Biochemical pharmacology 69 (4), 541-550, 2005 | 688 | 2005 |
Neurotoxicity of pesticides: a brief review LG Costa, G Giordano, M Guizzetti, A Vitalone Front Biosci 13 (4), 1240-1249, 2008 | 514 | 2008 |
Developmental neuropathology of environmental agents LG Costa, M Aschner, A Vitalone, T Syversen, OP Soldin Annu. Rev. Pharmacol. Toxicol. 44 (1), 87-110, 2004 | 400 | 2004 |
Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity LG Costa, TB Cole, A Vitalone, CE Furlong Clinica Chimica Acta 352 (1-2), 37-47, 2005 | 287 | 2005 |
Organophosphorus insecticides chlorpyrifos and diazinon and oxidative stress in neuronal cells in a genetic model of glutathione deficiency G Giordano, Z Afsharinejad, M Guizzetti, A Vitalone, TJ Kavanagh, ... Toxicology and applied pharmacology 219 (2-3), 181-189, 2007 | 266 | 2007 |
Hepatotoxicity of green tea: an update G Mazzanti, A Di Sotto, A Vitalone Archives of toxicology 89, 1175-1191, 2015 | 196 | 2015 |
Differential in vitro neurotoxicity of the flame retardant PBDE-99 and of the PCB Aroclor 1254 in human astrocytoma cells F Madia, G Giordano, V Fattori, A Vitalone, I Branchi, F Capone, LG Costa Toxicology letters 154 (1-2), 11-21, 2004 | 161 | 2004 |
What do we know about phytotherapy of benign prostatic hyperplasia? O Allkanjari, A Vitalone Life sciences 126, 42-56, 2015 | 129 | 2015 |
Early developmental exposure to BDE 99 or Aroclor 1254 affects neurobehavioural profile: interference from the administration route I Branchi, F Capone, A Vitalone, F Madia, D Santucci, E Alleva, LG Costa Neurotoxicology 26 (2), 183-192, 2005 | 126 | 2005 |
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer AFG Cicero, O Allkanjari, A Vitalone, GM Busetto, T Cai, G Larganà, ... ARCHIVIO ITALIANO DI UROLOGIA ANDROLOGIA 91 (3), 139-152, 2019 | 124 | 2019 |
Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test B Tita, H Abdel-Haq, A Vitalone, G Mazzanti, L Saso Il Farmaco 56 (5-7), 341-343, 2001 | 117 | 2001 |
Anti-proliferative effect on a prostatic epithelial cell line (PZ-HPV-7) by Epilobium angustifolium L. A Vitalone, F Bordi, C Baldazzi, G Mazzanti, L Saso, B Tita Il Farmaco 56 (5-7), 483-489, 2001 | 107 | 2001 |
Gellan gum methacrylate and laponite as an innovative nanocomposite hydrogel for biomedical applications S Pacelli, P Paolicelli, G Moretti, S Petralito, S Di Giacomo, A Vitalone, ... European Polymer Journal 77, 114-123, 2016 | 106 | 2016 |
Characterization of the Effect of Epilobium Extracts on Human Cell Proliferation A Vitalone, J McColl, D Thome, LG Costa, B Tita Pharmacology 69 (2), 79-87, 2003 | 106 | 2003 |
Plant-derived nutraceuticals and immune system modulation: an evidence-based overview A Di Sotto, A Vitalone, S Di Giacomo Vaccines 8 (3), 468, 2020 | 79 | 2020 |
Extracts of various species of Epilobium inhibit proliferation of human prostate cells A Vitalone, M Guizzetti, LG Costa, B Tita Journal of Pharmacy and Pharmacology 55 (5), 683-690, 2003 | 77 | 2003 |
Surveillance of suspected adverse reactions to natural health products: the case of propolis F Menniti-Ippolito, G Mazzanti, A Vitalone, F Firenzuoli, C Santuccio Drug Safety 31, 419-423, 2008 | 74 | 2008 |
An in vitro approach to assess the toxicity of certain food contaminants: methylmercury and polychlorinated biphenyls LG Costa, V Fattori, G Giordano, A Vitalone Toxicology 237 (1-3), 65-76, 2007 | 73 | 2007 |
Injectable and photocross-linkable gels based on gellan gum methacrylate: A new tool for biomedical application S Pacelli, P Paolicelli, I Dreesen, S Kobayashi, A Vitalone, MA Casadei International journal of biological macromolecules 72, 1335-1342, 2015 | 65 | 2015 |
Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health A Vitalone, F Menniti-Ippolito, PA Moro, F Firenzuoli, R Raschetti, ... European journal of clinical pharmacology 67, 215-224, 2011 | 54 | 2011 |